GKOS Covered Call Strategy
GKOS (Glaukos Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
GKOS (Glaukos Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $11.01B, a beta of 0.76 versus the broader market, a 52-week range of 73.16-186.75, average daily share volume of 943K, a public-listing history dating back to 2015, approximately 1K full-time employees. These structural characteristics shape how GKOS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.76 places GKOS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on GKOS?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
GKOS snapshot
As of August 14, 2026, spot at $184.94, ATM IV 37.40%, IV rank 0.00%, expected move 10.72%. The covered call on GKOS below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on GKOS specifically: GKOS IV at 37.40% is on the cheap side of its 1-year range, which means a premium-selling GKOS covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 10.72% (roughly $19.83 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GKOS expiries trade a higher absolute premium for lower per-day decay. Position sizing on GKOS should anchor to the underlying notional of $184.94 per share and to the trader's directional view on GKOS stock.
GKOS covered call setup
The GKOS covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GKOS at $184.94 on that close, the first option leg uses a $195.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GKOS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GKOS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $184.94 | long |
| Sell 1 | Call | $195.00 | $4.90 |
GKOS covered call risk and reward
- Net Premium / Debit
- -$18,004.00
- Max Profit (per contract)
- $1,496.00
- Max Loss (per contract)
- -$18,003.00
- Breakeven(s)
- $180.04
- Risk / Reward Ratio
- 0.083
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
GKOS covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on GKOS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$18,003.00 |
| $40.90 | -77.9% | -$13,913.98 |
| $81.79 | -55.8% | -$9,824.97 |
| $122.68 | -33.7% | -$5,735.95 |
| $163.57 | -11.6% | -$1,646.94 |
| $204.46 | +10.6% | +$1,496.00 |
| $245.35 | +32.7% | +$1,496.00 |
| $286.24 | +54.8% | +$1,496.00 |
| $327.13 | +76.9% | +$1,496.00 |
| $368.02 | +99.0% | +$1,496.00 |
When traders use covered call on GKOS
Covered calls on GKOS are an income strategy run on existing GKOS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
GKOS thesis for this covered call
The market-implied 1-standard-deviation range for GKOS extends from approximately $165.11 on the downside to $204.77 on the upside. A GKOS covered call collects premium on an existing long GKOS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether GKOS will breach that level within the expiration window. Current GKOS IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on GKOS at 37.40%. As a Healthcare name, GKOS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GKOS-specific events.
GKOS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GKOS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GKOS alongside the broader basket even when GKOS-specific fundamentals are unchanged. Short-premium structures like a covered call on GKOS carry tail risk when realized volatility exceeds the implied move; review historical GKOS earnings reactions and macro stress periods before sizing. Always rebuild the position from current GKOS chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on GKOS?
- A covered call on GKOS is the covered call strategy applied to GKOS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With GKOS stock at $184.94 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed GKOS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are GKOS covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the GKOS covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 37.40%), the computed maximum profit is $1,496.00 per contract and the computed maximum loss is -$18,003.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GKOS covered call?
- The breakeven for the GKOS covered call priced on this page is roughly $180.04 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The GKOS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.72%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on GKOS?
- Covered calls on GKOS are an income strategy run on existing GKOS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current GKOS implied volatility affect this covered call?
- GKOS ATM IV is at 37.40% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.